REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF MANDATORY HEALTH INSURANCE COVERAGE FOR BIOMARKER TESTING.
Reported from HHS (Stand. Com. Rep. No. 3402), as amended (SD 1), with recommendation of referral to WAM.
Summary
The Senate concurrent resolution directs the state auditor to evaluate the social and financial consequences of requiring health insurers, Medicaid plans, and other health programs to cover biomarker testing. It affects patients who need the tests, insurers who would provide coverage, and the legislature, which will receive the auditor’s findings before deciding on any mandate. The review is meant to inform policy decisions about expanding coverage for precision‑medicine tests.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SCR 76 changes status, plus AI-powered summaries and stage predictions.
Sign up free